Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2021-04-23 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) providing an update on a specific project (Nanakramguda Project) related to possession and cost adjustments. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to continuous disclosure obligations for listed companies. The content is an update on a project status and board approval related to asset possession and cost revision, not a financial report, earnings release, or management discussion. The document length is short (1514 characters) and it is an announcement of a specific event or update rather than a detailed report or financial statement. This fits best under Regulatory Filings (RNS), which is a general category for regulatory announcements and disclosures that do not fit other specific categories.
2021-04-23 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice regarding the transfer of unclaimed dividends and underlying equity shares to the Investor Education and Protection Fund (IEPF) as per Section 124(6) of the Companies Act, 2013 and related rules. It includes details about the process, deadlines, and shareholder communication. There are no financial statements, management discussion, or detailed financial data. The document is an official announcement to shareholders and stock exchanges about the transfer of shares and dividends to IEPF, which is a regulatory compliance disclosure. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a regulatory announcement related to compliance and shareholder information. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is 8882 characters, which is substantial but the content is clearly an announcement rather than a full report.
2021-04-16 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is an official communication from Neuland Laboratories Limited to stock exchanges regarding the assignment of credit ratings by CRISIL Ratings. It includes detailed information about the credit ratings assigned to various bank facilities and loans, along with disclaimers about the nature of the ratings. The document is an update on the company's credit rating status, which relates to financing and capital structure. It is not a full financial report, audit report, or earnings release. It is not a regulatory filing or announcement of a report publication. The content fits best under Capital/Financing Update (CAP) as it provides information on credit ratings affecting the company's financing and debt instruments.
2021-04-14 English
Annual Disclosure
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges referencing a SEBI circular about fund raising by issuance of debt securities by large corporates. The letter confirms that the company does not fall under the category of large corporates as per the circular. It is a regulatory compliance communication rather than a financial report or announcement of financial results. The document is short (1426 characters) and serves as a regulatory filing to update the exchanges on the company's status with respect to the SEBI circular. Therefore, it fits best under Regulatory Filings (RNS).
2021-04-13 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, concerning the financial year 2020-21. It states that the declarant and persons acting in concert have not made any encumbrance of shares other than those already disclosed. The document is a formal declaration related to shareholding and compliance with takeover regulations, not a financial report or earnings release. It fits the category of Major Shareholding Notification (MRQ) as it pertains to disclosures about share ownership and encumbrances under SEBI regulations.
2021-04-09 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulations 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It contains detailed information about shareholding, promoters, and persons acting in concert as of March 31, 2021. The document is addressed to stock exchanges and is a regulatory disclosure about substantial acquisition of shares and takeovers. It is not a financial report, earnings release, or management discussion. It fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds as per regulatory requirements.
2021-04-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.